Anders Sonnerborg
Overview
Explore the profile of Anders Sonnerborg including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
246
Citations
5568
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hajikhezri Z, Zygouras I, Sonnerborg A, van Domselaar R
Cell Death Discov
. 2025 Feb;
11(1):44.
PMID: 39905001
The persistence of HIV-1 latency reservoirs in CD4 T cells is a significant obstacle for curing HIV-1. Shock-and-kill strategies, which aim to reactivate latent HIV-1 followed by cytotoxic clearance, have...
2.
Elvstam O, Ryom L, Neesgaard B, Tau L, Gunthard H, Zangerle R, et al.
Open Forum Infect Dis
. 2025 Feb;
12(2):ofaf016.
PMID: 39896984
Background: HIV viremia has been considered a cardiovascular disease (CVD) risk factor, but many studies have had insufficient data on potential confounders. We explored the association between viremia and CVD...
3.
Di Teodoro G, Siciliano F, Guarrasi V, Vandamme A, Ghisetti V, Sonnerborg A, et al.
Comput Med Imaging Graph
. 2025 Jan;
120:102484.
PMID: 39808870
Predicting the outcome of antiretroviral therapies (ART) for HIV-1 is a pressing clinical challenge, especially when the ART includes drugs with limited effectiveness data. This scarcity of data can arise...
4.
Lundgren E, Locke M, Romero-Severson E, Dimitrijevic M, Axelsson M, Andersson E, et al.
Euro Surveill
. 2024 Oct;
29(42).
PMID: 39421951
BackgroundSweden reached the UNAIDS 90-90-90 target in 2015. It is important to reassess the HIV epidemiological situation due to ever-changing migration patterns, the roll-out of PrEP and the impact of...
5.
Rupasinghe D, Bansi-Matharu L, Law M, Zangerle R, Rauch A, Tarr P, et al.
Clin Infect Dis
. 2024 Aug;
80(2):404-416.
PMID: 39117341
Background: With integrase strand transfer inhibitor (INSTI) use associated with increased body mass index (BMI) and BMI increases associated with higher diabetes mellitus (DM) risk, we explored the relationships between...
6.
Narayanan A, Kieri O, Vesterbacka J, Manoharan L, Chen P, Ghorbani M, et al.
Sci Rep
. 2024 Aug;
14(1):17820.
PMID: 39090139
The gut and oral microbiome is altered in people living with HIV (PLWH). While antiretroviral treatment (ART) is pivotal in restoring immune function in PLWH, several studies have identified an...
7.
Giammarino F, Sonnerborg A, Cena-Diez R
Front Cell Infect Microbiol
. 2024 Jun;
14:1334126.
PMID: 38915925
Introduction: The naturally occurring dipeptide Tryptophylglycine (WG) is enhanced in human immunodeficiency virus (HIV-1) infected Elite Controllers (EC). We have shown that this dipeptide has an anti-HIV-1 effect and evaluated...
8.
Bai X, Sonnerborg A, Nowak P
Curr Opin HIV AIDS
. 2024 Jun;
19(5):261-267.
PMID: 38874425
Purpose Of Review: To unravel the current knowledge and possible link between the gut microbiome and HIV-1 virological control in elite controllers (EC), who can suppress viral replication in the...
9.
Naver L, Albert J, Carlander C, Gisslen M, Pettersson K, Soeria-Atmadja S, et al.
Infect Dis (Lond)
. 2024 May;
56(8):657-668.
PMID: 38805265
In May 2024, the Swedish Reference Group on Antiviral Therapy updated the guidelines on management of HIV infection in pregnancy. The most important recommendations and revisions were: (i) ART during...
10.
Di Teodoro G, Pirkl M, Incardona F, Vicenti I, Sonnerborg A, Kaiser R, et al.
Bioinformatics
. 2024 May;
40(6).
PMID: 38775719
Motivation: In predicting HIV therapy outcomes, a critical clinical question is whether using historical information can enhance predictive capabilities compared with current or latest available data analysis. This study analyses...